Detechgene returns from Web Summit Qatar with strong results, reinforcing its role as an innovation partner for the MENA region.

Detechgene joined global innovators in Düsseldorf to explore the future of healthcare, from AI-driven solutions to next-gen diagnostics. At the BIO.NRW / Wirtschaft.NRW stand, we presented our vision for rapid, scalable molecular diagnostics addressing key clinical challenges.

Detechgene GmbH, a Cologne biotech startup, has won the Rheinland Award in the Founding category for its innovative PCR rapid test.

Detechgene was selected as one of the top 5 startups from over 100 applicants in North Rhine-Westphalia for the Senkrechtstarter Award 2025. The final took place on September 16, 2025, at the Starlight Express Theater in Bochum, where the team pitched their data-driven diagnostics solutions to a renowned jury and audience.

Detechgene secures €3M in its second seed round, led by Neoteq Ventures with backing from NRW.BANK, Aquarius Invest, Meerkat Holding GmbH, and Campus Capital. The funding accelerates Detechgene’s mission to deliver fast, mobile, and reliable diagnostics worldwide with its PCR to Go platform. With strong investor backing and proven scalability, Detechgene is advancing toward transforming decentralized molecular diagnostics globally.

NRW is leading the way in medical innovation! Minister Mona Neubaur’s tour of start-ups in Düsseldorf, Bonn, and Cologne highlights groundbreaking advancements in diagnostics and therapies. Discover how collaboration between research, businesses, and start-ups is shaping the future of healthcare—and boosting the economy.

Detechgene is proud to join the Clinical Virology Network (CVN) as a bronze partner, collaborating with industry leaders like AstraZeneca and Sanofi. Together, we aim to enhance real-time pathogen surveillance and strengthen public health responses to infectious diseases.

Detechgene’s journey through Nigeria’s innovation ecosystem, part of the WIN.Africa initiative, revealed exciting market potential and sparked collaborations with startups, government bodies, and global companies like BASF and Beiersdorf. A glimpse into the future of cross-border innovation in Africa.

Detechgene is part of the ZukunftBIO.NRW, securing funding from a €15M initiative to bring biotech innovations to market. Their project DetechTest (funded with ~€1.16M) focuses on mobile, high-precision diagnostics using LAMP-based detection—enabling lab-quality testing anywhere. In collaboration with BioEcho Life Sciences GmbH and the University Hospital Cologne, Detechgene is developing a portable device for rapid infectious disease detection, aiming for market readiness and scalable production.

Detechgene’s journey to @MedtecJapan and CPHI Japan unveiled a world of cutting-edge innovation and digital healthcare advancements. From forging new connections to planning future collaborations, Japan’s blend of technology, hospitality, and inspiration left a lasting impact.

Detechgene has relocated to BioCampus Cologne, a leading biotech hub hosting 30+ companies, including innovators like RIMASYS, BioEcho Life Sciences GmbH, and BluCon Biotech GmbH, alongside global players such as Sanofi, Lonza, and Bayer. With new labs and offices, Detechgene gains access to top-tier infrastructure, strong networking opportunities, and an ideal environment to scale innovation and growth.